Scalper1 News
Drugmaker Aptalis Holdings filed to go public Thursday in an IPO expected to raise around half a billion dollars, as the company formerly traded as Axcan Pharma returns in a new incarnation. Private-equity firm TPG Capital acquired Axcan in 2007 and has merged it with several other companies, notably Eurand Pharmaceuticals, acquired for $583 million in 2011. The company has a substantial portfolio in cystic fibrosis and gastrointestinal diseases, Scalper1 News
Scalper1 News